Sequential therapy with caspofungin and fluconazole for Candida albicans infection

Antimicrobial Agents and Chemotherapy
Francesco BarchiesiGiorgio Scalise

Abstract

A sequential therapy of caspofungin (CAS) and fluconazole (FLC) administration for treatment of Candida albicans infection was investigated. Treatment with CAS followed by FLC was as effective as CAS treatment given alone for the same duration. Our data suggest that switching from CAS to FLC is a potentially explorable therapeutic option for treatment of systemic candidiasis.

References

Jan 27, 1994·The New England Journal of Medicine·J A Como, W E Dismukes
Nov 26, 1997·Antimicrobial Agents and Chemotherapy·K BartizalJ Balkovec
Jun 29, 1999·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F BarchiesiM G Rinaldi
Dec 26, 2001·Antimicrobial Agents and Chemotherapy·Sevtap ArikanJohn H Rex
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·William R KirkpatrickThomas F Patterson
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Sofia PereaThomas F Patterson
Dec 20, 2002·The New England Journal of Medicine·Jorge Mora-DuarteUNKNOWN Caspofungin Invasive Candidiasis Study Group
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·John R GraybillRobert A Larsen
Dec 4, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Dimitrios P Kontoyiannis, Russell E Lewis

❮ Previous
Next ❯

Citations

Dec 7, 2007·Antimicrobial Agents and Chemotherapy·Elisabetta SpreghiniFrancesco Barchiesi
Mar 17, 2007·Current Eye Research·Tuncay KusbeciUmit Ubeyt Inan
Jun 29, 2006·Current Opinion in Infectious Diseases·Karl V Clemons, David A Stevens
Apr 17, 2019·Journal of Fungi·Ambre F ChapuisDonna M MacCallum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.